绝经后子宫内膜癌病理特点分析  

Analysis of pathological characteristics of postmenopausal endometrial cancer

作　　者：胡丁月 HU Ding-yue(First Department of Gynecology,Jinzhou Maternity and Infant Hospital,Jinzhou 121000,China)

机构地区：[1]锦州市妇婴医院妇一科,121000

出　　处：《中国现代药物应用》2023年第4期65-67,共3页Chinese Journal of Modern Drug Application

摘　　要：目的研究绝经后子宫内膜癌的病理特点。方法回顾性分析122例子宫内膜癌患者的临床资料,统计绝经后子宫内膜癌的人数,并分析子宫内膜癌患者常规病理特点。结果122例子宫内膜癌患者中绝经后子宫内膜癌患者56例,占45.90%;非绝经后子宫内膜癌患者66例,占54.10%。病理类型中,绝经后子宫内膜癌患者子宫内膜样腺癌38例(67.86%),非子宫内膜样腺癌18例(32.14%);非绝经后子宫内膜癌患者子宫内膜样腺癌20例(30.30%),非子宫内膜样腺癌46例(69.70%)。临床分期中,绝经后子宫内膜癌患者Ⅰ期23例(41.07%),Ⅱ期20例(35.71%),Ⅲ期10例(17.86%),Ⅳ期3例(5.36%);非绝经后子宫内膜癌患者Ⅰ期11例(16.67%),Ⅱ期20例(30.30%),Ⅲ期25例(37.88%),Ⅳ期10例(15.15%)。细胞分化中,绝经后子宫内膜癌患者高度分化(G1)33例(58.93%)、中度分化(G2)15例(26.79%)、低度分化(G3)8例(14.29%);非绝经后子宫内膜癌患者G18例(12.12%)、G231例(46.97%)、G327例(40.91%)。肌层浸润程度中,绝经后子宫内膜癌患者≤1/2肌层40例(71.43%),>1/2肌层16例(28.57%);非绝经后子宫内膜癌患者≤1/2肌层22例(33.33%),>1/2肌层44例(66.67%)。绝经后子宫内膜癌和非绝经后子宫内膜癌患者子宫内膜样腺癌、细胞分化G1、肌层浸润≤1/2的常规病理特点比较,差异有统计学意义(P<0.05)。结论和非绝经后子宫内膜癌相比,绝经后子宫内膜癌的主要病理特点表现为子宫内膜样腺癌、临床分期Ⅰ~Ⅱ期、细胞分化G1、肌层浸润≤1/2,需要针对患者的需求等提供相对应的干预和治疗,以便保证患者预后。Objective To study the pathological characteristics of postmenopausal endometrial cancer.Methods The clinical data of 122 cases of endometrial cancer patients were retrospectively analyzed,the number of postmenopausal endometrial cancer patients was counted,and the conventional pathological characteristics of endometrial cancer patients were analyzed.Results Among the 122 patients with endometrial cancer,56 cases(45.90%)were postmenopausal endometrial cancer,and 66 cases(54.10%)were non-postmenopausal endometrial cancer.Pathological types:there were 38 cases(67.86%)of endometrioid adenocarcinoma,and 18 cases(32.14%)of non-endometrioid adenocarcinoma in postmenopausal endometrial cancer patients.There were 20 cases(30.30%)of endometrioid adenocarcinoma and 46 cases(69.70%)of non-endometrioid adenocarcinoma in nonpostmenopausal endometrial cancer patients.Clinical stages:23 cases(41.07%)of postmenopausal endometrial carcinoma patients were in stageⅠ,20 cases(35.71%)in stageⅡ,10 cases(17.86%)in stageⅢ,and 3 cases(5.36%)in stageⅣ;11 cases(16.67%)of non-postmenopausal endometrial cancer patients in stageⅠ,20 cases(30.30%)in stageⅡ,25 cases(37.88%)in stageⅢ,and 10 cases(15.15%)in stageⅣ.Cell differentiation:high differentiation(G1)in 33 cases(58.93%),moderate differentiation(G2)in 15 cases(26.79%),poor differentiation(G3)in 8 cases(14.29%)for postmenopausal endometrial cancer patients;G1 in 8 cases(12.12%),G2 in 31 cases(46.97%),G3 in 27 cases(40.91%)for non-postmenopausal endometrial cancer patients.Degree of myometrial infiltration:40 cases(71.43%)with≤1/2 myometrium and 16 cases(28.57%)with>1/2 myometrium in postmenopausal endometrial cancer patients;22 cases(33.33%)with≤1/2 myometrium and 44 cases(66.67%)with>1/2 myometrium in non-postmenopausal endometrial cancer patients.The conventional pathological characteristics of endometrioid adenocarcinoma,cell differentiation G1,and myometrial infiltration≤1/2 in postmenopausal and non-postmenopausal endometrial cancer patients were compared,and the

关 键 词：子宫内膜癌 绝经后 病理特点 

分 类 号：R737.33[医药卫生—肿瘤]